July 26, 2021
Article
This approval of the non-live, recombinant sub-unit adjuvanted vaccine, Shingrix, is for the prevention of shingles in adults aged 18 years and older with increased risk of immunodeficiency or immunosuppression.
This therapy becomes the first single-dose infusion to treat acute bacterial skin and skin structure infections (ABSSSI) in pediatric patients from birth.
November 12, 2020
CDC and WHO Data shows a 50% increase worldwide from 3 years ago.
October 23, 2020
“The compound appears to be safe and well-tolerated, [and we observed] excellent efficacy based on a very small sample size,” Peter G. Pappas, MD, said.
January 10, 2020
A closer look at the 2018 enterovirus A71 outbreak in Colorado highlights the need for non-sterile site testing to detect infections.
January 03, 2020
Treating parents colonized with S aureus reduced neonatal colonization with concordant S aureus strains when compared to placebo.
December 20, 2019
How many nursing homes have these microbes?
December 19, 2019
Global efforts to eliminate measles took a step backward, with the number of cases rising to 353,236 in 2018, up 167% from 132,413 cases in 2016.
December 17, 2019
Video
